| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
103,000,000 |
| Market
Cap: |
403.76(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$1.99 - $4.97 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Humacyte is engaged in the development and manufacture of off-the-shelf, universally implantable, bioengineered human tissues. Co. is utilizing its technology platform to develop proprietary, bioengineered, acellular human tissues for use in the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
4,750 |
198,275 |
| Total Buy Value |
$0 |
$0 |
$19,855 |
$784,399 |
| Total People Bought |
0 |
0 |
1 |
6 |
| Total Buy Transactions |
0 |
0 |
1 |
14 |
| Total Shares Sold |
0 |
0 |
33,422,190 |
40,807,494 |
| Total Sell Value |
$0 |
$0 |
$94,707,915 |
$120,632,535 |
| Total People Sold |
0 |
0 |
4 |
4 |
| Total Sell Transactions |
0 |
0 |
22 |
37 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Niklason Laura E |
President, CEO and Director |
• • • |
2021-08-26 |
4 |
B |
$10.00 |
$15,225,000 |
I/I |
1,522,500 |
20,452,504 |
2.64 |
-48% |
|
| Niklason Laura E |
President, CEO and Director |
• • • |
2021-08-26 |
4 |
A |
$0.00 |
$0 |
I/I |
18,930,004 |
18,930,004 |
|
- |
|
| Niklason Laura E |
President, CEO and Director |
• • • |
2021-08-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,148,240 |
1,148,240 |
|
- |
|
| Lawson Jeffrey Harold |
Chief Surgical Officer |
• • – |
2021-08-26 |
4 |
A |
$0.00 |
$0 |
D/D |
7,877 |
7,877 |
|
- |
|
| Wallace Max N. |
Director |
– • – |
2021-08-26 |
4 |
A |
$0.00 |
$0 |
D/D |
49,986 |
49,986 |
|
- |
|
| Prichard Heather Ledbetter |
Chief Operating Officer |
• – – |
2021-08-26 |
4 |
A |
$0.00 |
$0 |
D/D |
2,625 |
2,625 |
|
- |
|
56 Records found
|
|
Page 3 of 3 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.17 (4.16%) 
